Home » Topics » BioWorld Science

BioWorld Science
RSS

Reata initiates first-in-human study with allosteric RORgammat inhibitor RTA-1701

June 22, 2018

PTC Therapeutics presents updated preliminary data from FIREFISH

June 22, 2018

Metastatic breast cancer regression by immunotherapy with TILs enriched for neoantigen reactivity

June 22, 2018

FDA grants QIDP designation to ACX-362E to treat C. difficile infection

June 22, 2018

Shanghai Meton Pharmaceutical patents NADP+ inhibitors

June 21, 2018

MTHFD2 inhibitors identified at Daiichi Sankyo

June 21, 2018

Amgen discovers apelin receptor agonists

June 21, 2018

Teijin Pharma presents CDK4/cyclin D3 and/or CDK6/cyclin D3 inhibitors

June 21, 2018

Insights into the orthosteric and allosteric action of C5aR antagonists to guide drug development

June 21, 2018

TG Therapeutics and Novimmune enter global agreement to develop and commercialize TG-1801

June 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...